 Shares of Principia Biopharma Inc NASDAQ:PRNB have received an average rating of Buy from the six ratings firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating on the company. The average ... 